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Between December 31, 2019, and January 3, 2020, a total
of 44 patients presented in Wuhan, Hubei Province, China,
with pneumonia of unknown etiology. By January 7, 2020,
scientists had isolated a new type of coronavirus, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
from these patients. It was hypothesized that the outbreak
was associated with a seafood market in Wuhan (1).
China promptly adopted public health measures to prevent
and control the epidemic, including isolating patients, mon-
itoring their contacts, and developing diagnostic and treat-
ment procedures (2). However, the number of confirmed cases
continued to increase, and the disease spread to other countries.
The first cases of coronavirus disease (COVID-19) outside
China were reported in Thailand, Japan, and Korea. Since then,
COVID-19 has spread to American and European territories.
By the time the World Health Organization declared a pan-
demic on March 11, 2020, there were approximately 118,000
cases of COVID-19, with 4,291 deaths in 114 countries (1).
In the American continent, the first case was reported in
the United States of America on January 21, 2020, followed
by Canada, which reported its first case four days later. In
South America, the first case was confirmed on February 26,
2020 in the city of São Paulo, Brazil. By May 7, 2020, the
country had already 135,106 confirmed cases and 9,146
deaths (3). However, these numbers are likely underreported.
In addition to the absence of proper screening mechanisms for
asymptomatic patients (4), Brazil’s health system suffers from
a chronic lack of testing for suspected cases and deaths, as is
the case in a number of developing countries.
Clinical characteristics of COVID-19
SARS-CoV-2 may remain viable in the environment for up
to 72 hours (5). Besides, an infected respiratory droplet can
spread viral loads in the environment up to 2 meters from
where it is generated through coughing, sneezing, or speak-
ing. In this manner, COVID-19 is acquired either by inhaling
droplets or touching a contaminated surface and then touch-
ing the nose, mouth, or eyes. An infected patient usually
transmits the disease for an average period of 7 days after the
onset of symptoms. However, preliminary data suggests that
transmission may occur even without the appearance of any
symptoms (6).
According to a recent meta-analysis, the most common
clinical symptoms of COVID-19 are fever, cough, myalgia,
fatigue, expectoration, and dyspnea (7). Besides, headache,
dizziness, sore throat, and gastrointestinal symptoms have
also been described (8). The intensity of symptoms suffered
may vary. While the majority of individuals are asympto-
matic, clinical presentations range from mild symptoms
to pneumonia and can lead to death (9). The most severe
complications include acute respiratory distress syndrome,
arrhythmia, and shock (10), with intensive care admission
rates of approximately 25 to 30% (9). Depending on the
patient’s clinical profile, the mortality rate associated with
COVID-19 is estimated to range from 2 to 15% (7). There are
no known treatments or vaccines.
While everyone is susceptible to COVID-19, some patients
may have a higher risk of developing the most severe forms
of the disease. Such cases are associated with a higher rate of
hospitalization, worse prognosis, and higher mortality rate
(10,11). People more at risk include the elderly, smokers, and
those with underlying comorbidities, such as cardiovascular
and cerebrovascular disease, hypertension, diabetes mellitus,
chronic obstructive pulmonary disease, malignancy, and
chronic kidney disease (12,13).
Vulnerability of patients with a psychiatric
condition
It is well-known that a pandemic can result in a range
of psychiatric morbidities in the general population (14).
Similarly, considerable widespread psychological impact
has been reported after a quarantine period (15). Wang
et al. (16) reported that more than half of 1,210 random
subjects from 194 Chinese cities rated their psychologi-
cal impact during the initial stage of the COVID-19 out-
break as moderate to severe. Despite the lack of research,
it is reasonable to hypothesize that people with a history
of mental illness may be more sensitive to the psychologi-
cal effects of a pandemic, increasing the risk of a mental
relapse (17).
In addition to the worsening of their psychopathological
symptoms, psychiatric patients have a higher risk of con-
tracting an infectious disease than does the general popula-
tion, including pneumonia (18). In this regard, inpatients
seem especially vulnerable. During the initial periods ofDOI: 10.6061/clinics/2020/e2056
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the pandemic, a Chinese newspaper reported that at least
50 patients and 30 mental health professionals in Wuhan’s
largest psychiatric hospital had COVID-19. The intense
interpersonal contact inherent to a psychiatric unit promotes
the right conditions for the rapid dissemination of any
etiological agent. Inpatients frequently exhibit behavioral
disorganization or cognitive impairments that compromise
their ability to understand risks and adhere to preventive
and hygiene measures. In addition, mental health profes-
sionals themselves are often not routinely trained to deal
with infectious diseases (19).
Patients with mental health conditions that have COVID-
19 have higher hospitalization rates and worse prognosis,
especially those with more severe disorders, in whom there is
a high prevalence of medical comorbidities in this population
(20). According to a recent review (21), patients with schi-
zophrenia or bipolar affective disorder have an increased risk
of cardiovascular (e.g., coronary heart disease, heart failure,
hypertension, angina, myocardial infarction), cerebrovas-
cular (e.g., stroke, transient ischemic attacks), endocrine
(e.g., diabetes mellitus, thyroid disorders), respiratory (e.g.,
asthma, chronic obstructive pulmonary disease), infectious
(e.g., hepatitis C, immune deficiency and autoimmune
diseases. These effects appear to be secondary to both men-
tal illness and the use of psychotropic drugs. Depression
has also been associated with cardiovascular disease,
immunosuppression, and cancer (22). Finally, higher rates
of smoking in patients with psychiatric disorders have been
well-described (23).
The COVID-19 pandemic and electroconvulsive
therapy services
Electroconvulsive therapy (ECT) is considered one of the
most effective and safe interventions in psychiatry, particu-
larly for cases that require a rapid therapeutic response,
such as those associated with suicidal ideation, progressive
clinical deterioration, or catatonia (24). Such characteristics
have several implications in the context of the COVID-19
pandemic. First, ECT services often bring together elderly
(25) and critically ill individuals, who have higher rates of
medical comorbidities (20), poorer hygiene (26), and worse
cognitive profiles (27). This population has a higher COVID-19
mortality rate (7).
Besides, during a pandemic, health resources are scarce and
non-vital services may be closed or repurposed. Despite its
importance in life-threatening situations, ECT has historically
been classified as an elective treatment, so many ECT services
may be limited. This can have catastrophic consequences for
patients with severe mental health disorders (28), especially
Figure 1 - Instructions for reassessing electroconvulsive therapy (ECT) frequency.
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considering that such a social context can trigger and aggra-
vate psychiatric symptoms (14–16). Unfortunately, a team
from a general hospital in Singapore (29) has already reported
the suicide of a patient with depression whose ECT treatment
was impaired by limited anesthetic resources because of the
COVID-19 pandemic.
Another implication for ECT units is related to anesthetic
practices required for the procedure. ECT is universally
performed under general anesthesia, to provide comfort and
safety. After anesthetic induction, the patient’s airways are
usually maintained with bag-mask ventilation, whereas
endotracheal intubation is rarely required (30). Such inter-
ventions, in particular non-invasive ventilation, may gen-
erate a localized aerosol, which carries a high risk of
contagion to those closely involved in the procedure (31).
Thus, there is a risk for both patients and staff.
As such, there are many challenges with the delivery of
ECT in the current COVID-19 pandemic. Efficacious strate-
gies need to be identified so that ECTservices can continue to
operate throughout the COVID-19 pandemic, according to
available resources.
ECT service at the University of São Paulo medical
school
The mental health system is precarious in Brazil, especially
regarding ECT. The population of Brazil exceeds 210 million,
of which 10 million live in the city of São Paulo, one of the
most populated metro areas worldwide (32). To the best of
our knowledge, there are only 11 institutions that offer ECT
free of charge to patients across the country, meaning that
there is one public ECT service for every 19 million
inhabitants. Most large cities do not have this kind of service
because the procedure is not financed by the Ministry of
Health. There are private clinics for those that can afford to
pay; however, the only option for those that cannot are
public institutions linked to medical universities. Never-
theless, both are hard to find (33).
The Institute of Psychiatry of Clinics Hospital of the
University of São Paulo Medical School (IPq-HCFMUSP)
offers outpatient and hospital treatments for a range of
mental health disorders, including neuromodulation techni-
ques and other biological therapies. The Institute assists in
research, teaching, and assistance for all of South America,
integrating a hospital complex (HCFMUSP) that offers 2,400
hospital beds and 600,000 outpatient consultations to the
public each year.
Our ECT service performs between 500 and 600 ECT
procedures monthly. Of these, 75% are delivered to out-
patients and 25% to inpatients. The opening hours are from
8 a.m. to 3 p.m. Because of the lack of ECTunits in the country,
the service treats patients from several different geographic
regions and social classes. Regarding finance, most assistance
is provided through the Institute’s limited resources.
The risk of contamination within the ECT service of IPq-
HCFMUSP during the COVID-19 pandemic is especially
high because of several factors. First, it is an outpatient clinic,
so there is the potential for an infected person to present.
Moreover, ECT patients often have difficulties in under-
standing COVID-19 prevention measures. Second, as the
service assists both outpatients and inpatients, the virus may
enter the wards, contaminating other patients who are not
receiving ECT. Third, patient turnover is remarkably high,
and there is close and repetitive contact between patients,
their peers, and health professionals, inside a confined
environment with restricted air circulation.
In addition to contamination, lack of assistance is also a
risk factor. Most patients travel long distances to arrive at the
Institute. Because of the isolation measures in place to control
Figure 2 - Daily electroconvulsive therapy (ECT) procedures before and after the pandemic.
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the pandemic, mobility within and outside the city is restric-
ted, preventing some patients from accessing treatment.
Moreover, being a part of a hospital complex, the facilities
and resources of the ECT service may be repurposed to treat
patients with COVID-19, which would drastically decrease
its regular functioning. Considering its importance and the
lack of other similar units, the abrupt closure of our ECT
service would severely impact the delivery of ECT across
much of the country.
Measures to deal with the COVID-19 pandemic and
its immediate impacts
Since the quarantine was decreed by the Governor of
the State of São Paulo on February 24, 2020 (34), all people
with COVID-19 were isolated at the Central Institute of
HCFMUSP, whereas other cases were transferred to the
remaining units. For instance, IPq – HCFMUSP received
patients from Neurology and Neurosurgery departments.
We also made some changes to the ECT service facilities to
reduce the risk of contamination, according to the National
Health Surveillance Agency’s guidelines (35). From February
24, 2020, all individuals who require psychiatric hospitaliza-
tion are first being admitted to an isolated ward for 14 days
before being transferred to a regular ward. In addition, visits
by family members are limited. As a result of these measures,
we considered that the risk of contamination was lower for
inpatients than for outpatients, and we divided the service
period into two shifts, the first one reserved exclusively for
inpatients and the second, for outpatients.
For both groups of patients, we are providing educational
pamphlets (guidelines on hygiene and respiratory etiquette)
and hand sanitizer. In particular, for outpatients, we have
increased the frequency of cleaning of the waiting room,
and the chairs have been spread further apart with the
windows left open to improve ventilation. Waiting time has
also been drastically reduced. Additionally, we are screening
both outpatients and their families (now limited to one
per patient) for respiratory symptoms on arrival. In the
case of suspected COVID-19, appropriate preventive actions
are taken, and the patient is immediately referred to the
emergency department.
Regarding environmental measures, internal facilities with
frequent personal contact are cleaned with 70% alcohol after
each patient leaves to reduce the risk of contamination
between patients. The internal areas undergo daily terminal
cleaning with a neutral detergent. Afterward, the surfaces
are disinfected with chlorine-based products, especially the
most frequently touched surfaces and equipment (e.g., door
handles, telephones, tables, light switches, handrails and
grab bars, handles, gauntlets, and monitoring equipment).
The entire process is carefully supervised by our nurse
manager, who also ensures proper use of personal protective
equipment (PPE) by the entire team.
The PPE components were selected on the basis of the type
of contact each professional has with patients. In addition to
thoroughly cleaning their hands, support professionals who
work at reception or security have been instructed to wear a
surgical mask, gown, and procedure gloves. They continued,
as usual, to welcome patients through a glass panel. Doctors
and nurses have been instructed to wear full PPE (N95
masks, face shield, fluid-resistant gown, gloves, and hoods)
because ECT is considered an aerosol-generating procedure.
We reduced the number of practitioners in the ECT appli-
cation room to the minimum necessary, and all staff have
received training on how to use PPE correctly. In addition,
staff undergo periodic screening for respiratory symptoms.
Figure 3 - Daily electroconvulsive therapy (ECT) procedures per diagnosis.
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At the time of this report, there were two reported cases of
infection in our team, one receptionist and one anesthesiol-
ogist. Both of them remained isolated for 10 days and have
fully recovered.
Regarding the ECT procedure, the most important change
made was in relation to anesthesia. According to our pre-
vious protocol, we kept using disposable bite blocks and
exhalation filters attached to the bag-mask. Typically, ane-
sthetic induction includes etomidate 0.15-0.2 mg/kg IV or
propofol 1.0 mg/kg IV and succinylcholine 0.5-0.6 mg/kg IV,
followed by bag-mask ventilation with 100% oxygen. We
have decreased the dose of succinylcholine to 0.3-0.4 mg/kg
IV and replaced the bag-mask ventilation with 100% preo-
xygenation for 5 minutes. Interestingly, the side effects and
complication rates have remained the same, whereas
anesthetic recovery time is shorter for some patients. Indeed,
the results of Nazemroaya et al. (36) suggest that preox-
ygenation with 100% oxygen for 5 minutes is comparable to
bag-mask ventilation for ECT in terms of O2 saturation.
Finally, our team has been evaluating the possibility of
reducing the frequency of sessions for each patient. In this,
we consider factors such as the treatment stage and com-
orbidities (Figure 1), in addition to the opinion of the
referring psychiatrist. Once a patient’s treatment regimen
has been changed, he or she is routinely screened to prevent
mental health problems from worsening.
Right after the pandemic, there was a decrease in the daily
number of procedures (Figure 2 and Figure 3). Until May 7,
2020, two of our patients have died from COVID-19, a young
male and a female, both on maintenance ECT for schizo-
phrenia. Another patient, who had been receiving ECT for a
severe depressive episode, failed to attend treatment because
of reduced mobility in the city. Although a causal relation-
ship cannot be established, he had an unprecedented seizure
right after the abrupt stop of ECT.
Final considerations
The COVID-19 pandemic has been unprecedented. Some
experts believe that COVID-19 control strategies may be
required for at least another 2 years or more (37), which
could severely impact ECT services. Considering the indis-
pensable role of ECT, our report aims to promote commu-
nication and to draw attention to ECT units during the
COVID-19 pandemic, emphasizing the importance of devel-
oping strategies to mitigate its impact on ECT practice.
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